Roche Diagnostics is collaborating with the University of Liverpool to launch the Eye Cancer Artificial Intelligence Digital ...

Roche's Q4 results and innovative advancements make it a strong pick. Its late-stage pipeline supports our belief that there is still room for growth. See more.

The value that laboratories contribute to clinical decision-making is critical to the future of health care and enables people to live longer, healthier lives. Roche Diagnostics Corporation, the ...

Roche (RHHBY) unveiled its proprietary, breakthrough sequencing by expansion technology, establishing a new category of next-generation ...

Basel: Roche has announced that it has entered into an exclusive collaboration and licensing agreement with Zealand Pharma.

The POC Diagnostics Market is expected to grow from an estimated USD 51.26 billion in 2024 to USD 118.91 billion in 2033, at a CAGR of 9.8%. The global point-of-care (POC) diagnostics market is ...

Rise in prevalence of cancer and the necessary attention in early diagnosis and treatment to boost market demand, States Fact.MRRockville, MD, March 11, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, ...

Roche and Zealand reason petrelintide could deliver weight loss comparable to glucagon-like peptide 1 (GLP-1) receptor ...

Roche and its Genentech subsidiary are planning to hitch up their cardiovascular, renal and metabolism R&D work and shift it over to a new center in Harvard’s Enterprise Research Campus. | Roche and ...

Pharmaceutical giant Roche announces opening of an innovation centre at Harvard University's corporate research campus.